Director/PDMR Shareholding
Updated : 12:51
LEI: 213800EHT3TI1KPQQJ56
Director / PDMR Shareholding
In accordance with Article 19(3) of the Market Abuse Regulation (2014/596/EU), the transactions below were made by Directors / persons discharging managerial responsibility ("PDMRs") in the Company, or, where indicated, persons closely associated with a Director / PDMR. They reflect take up of Rights under the Rights Issue, connected with the New Synthomer Shares of 240 pence each in the Company held directly by the relevant Director or a person closely associated with them.
1. | Details of the person discharging managerial responsibilities / person closely associated
| |
(a) | Name
| Brendan Connolly |
2. | Reason for the notification
| |
(a) | Position / status
| Senior Independent Director |
(b) | Initial notification / Amendment
| Initial notification |
3. | Details of the Issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
(a) | Name | Synthomer plc
|
(b) | LEI | 213800EHT3TI1KPQQJ56
|
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
(a) | Description of the financial instrument, type of instrument
Identification code | Synthomer plc ordinary shares, 10p par value
GB0009887422
|
(b) | Nature of the transaction | Take up of Rights in relation to Synthomer plc 1 for 4 Rights Issue
|
(c) | Price(s) and volume(s) | Price(s): 240 pence per share Volume(s): 800
|
(d) | Aggregated information · Aggregated Volume · Price |
Volume: 800 Price: 240 pence per share
|
(e) | Date of the transaction | 29 July 2019
|
(f) | Place of the transaction | London Stock Exchange, main market (XLON) |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.